Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 11, 2017
OncoSec to Host Third Quarter Financial Conference Call on June 1, 2017
SAN DIEGO, May 11, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced today that the Company will ...
May 11, 2017
VBL Therapeutics Presents Data on VB-111 in Combination with Checkpoint Inhibitor at the 20th Annual ASGCT Meeting
TEL AVIV, Israel, May 11, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT) today announced new preclinical data indicating that treatment with ofranergene obadenovec (VB-111) augments ...
May 11, 2017
BioTime Presents Retinal Restoration Data at ARVO
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE MKT: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today announced that a poster related to the ...
May 11, 2017
Vermillion Reports First Quarter 2017 Results
AUSTIN, Texas, May 11, 2017 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company focused on gynecologic disease, reported on its financial results for the first ...
May 11, 2017
BIOPHYTIS: First patient-in in the United States and opening of 2 clinical centers for the SARA-OBS study on Sarcopenia
PARIS, May 11, 2017 (GLOBE NEWSWIRE) -- BIOPHYTIS (Alternext Paris:ALBPS), a biotechnology company specialized in the development of drug candidates to treat ageing diseases, has ...
May 11, 2017
Aimmune Therapeutics Enrolls First Patient in RAMSES (ARC007), a Phase 3 Clinical Trial of AR101 for the Treatment of Peanut Allergy
BRISBANE, Calif.--(BUSINESS WIRE)-- Aimmune Therapeutics, Inc. (AIMT), today announced the enrollment of its first patient in the Phase 3 RAMSES (ARC007) clinical trial of AR101 for ...
May 11, 2017
Catalyst Biosciences Reports First Quarter 2017 Financial Results and Provides Corporate Update
SOUTH SAN FRANCISCO, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address ...
May 10, 2017
Onxeo Announces Allowance of U.S. Patent for Livatag® in Hepatocellular Carcinoma
PARIS, May 10, 2017 (GLOBE NEWSWIRE) -- Onxeo S.A. (Euronext Paris:ONXEO) (NASDAQ Copenhagen:ONXEO), a clinical-stage biotechnology company specializing in the development of innovative drugs for ...
May 10, 2017
BioTime, Inc. Reports First Quarter Results and Recent Corporate Accomplishments
BioTime, Inc. (NYSE MKT and TASE: BTX), a clinical-stage biotechnology company developing and commercializing products addressing degenerative diseases, today reported financial results for the first quarter ...
May 10, 2017
Albireo Reports First Quarter 2017 Financial Results
BOSTON, May 10, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today reported ...
May 10, 2017
SciClone Reports First Quarter 2017 Financial Results
FOSTER CITY, Calif., May 10, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) today reported financial results for the quarter ended March 31, 2017. Revenues: In ...
May 10, 2017
DURECT Corporation Announces First Quarter 2017 Financial Results and Provides Corporate Update
CUPERTINO, Calif., May 10, 2017 /PRNewswire/ -- DURECT Corporation (DRRX) today announced financial results for the three months ended March 31, 2017 and provided a corporate ...
May 10, 2017
TRACON Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update
SAN DIEGO, May 10, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
May 10, 2017
TherapeuticsMD Announces Presentation at Bank of America Merrill Lynch 2017 Healthcare Conference on May 16
BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NYSE MKT: TXMD), an innovative women’s healthcare company, today announced that the company’s CEO Robert Finizio will present at the ...
May 10, 2017
TiGenix to present at the Crohn's and Colitis Foundation's Novel Technologies in Inflammatory Bowel Disease workshop in New York
Leuven (BELGIUM) - May 10, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory ...
May 10, 2017
OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Metastatic Melanoma
SAN DIEGO, May 10, 2017 /PRNewswire/ -- OncoSec Medical Incorporated ("OncoSec") (ONCS), a company developing DNA-based intratumoral cancer immunotherapies, has entered a clinical trial collaboration and ...
May 10, 2017
Sierra Oncology Receives Clearance to Enhance Ongoing Clinical Trials for SRA737
VANCOUVER, May 10, 2017 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a clinical stage drug development company focused on advancing next generation DNA Damage Response (DDR) ...
May 10, 2017
Bellerophon Announces $3.0 Million Registered Direct Offering
WARREN, N.J., May 10, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (BLPH), a clinical-stage biotherapeutics company, today announced that it has entered into a definitive agreement ...
May 10, 2017
Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate Progress
SAN DIEGO--(BUSINESS WIRE) -- Heron Therapeutics, Inc. (HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel best-in-class treatments to address some of ...
May 10, 2017
STRATA Skin Sciences, Inc. Announces the Appointment of James L. Coyne to its Board of Directors
HORSHAM, Pa., May 10, 2017 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to ...
Page 114 of 117